EU recommends copy of Enbrel arthritis drug from Samsung
November 20, 2015 at 07:09 AM EST
LONDON, Nov 20 (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a green light from the continent's regulators.
